Accentia looks to extend exclusive plan-filing period to March 24

By Lisa Kerner

Charlotte, N.C., March 10 - Accentia Biopharmaceuticals, Inc. filed an emergency motion to extend its exclusive plan-filing period to March 24 from March 10, according to a Wednesday filing with the U.S. Bankruptcy Court for the Middle District of Florida.

If a plan is filed by March 23, Accentia will have the exclusive right to solicit votes on that plan through May 24.

Accentia, a biopharmaceutical company based in Tampa, Fla., filed for bankruptcy on Nov. 10, 2008. Its Chapter 11 case number is 08-17795.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.